Lilly Weight Loss Drug Tirzepatide

Eli Lilly shares drop

Eli Lilly stock tumbles after new forecasts show weight-loss drug sales grow slower than expected

Eli Lilly (LLY) shares traded down more than 6% Tuesday after the company reported revenue guidance for the fourth quarter of 2024 that missed Wall Street expectations. Lilly revised its revenue guidance down 5%,

Hosted on MSN · 1d

Eli Lilly shares drop as drugmaker cuts revenue guidance on weight loss drug demand

Eli Lilly shares dropped after the drugmaker cut its 2024 revenue guidance, citing lower-than-expected demand for its obesity and diabetes drugs.

Daily · 2d

Copycat weight-loss drugs: Eli Lilly sues two medical spas

Two medical spas have been sued by Eli Lilly for selling unapproved products that claim to contain tirzepatide. Tirzepatide is the main ingredient in Zepbound, Lilly's famous

9don MSN

Ozempic 3.0? This drug causes the greatest weight loss — by far

Researchers from Canada reviewed the results of 26 trials to determine which of the weight loss jabs are the most effective ...

13don MSN

Pharma giant seeks to join lawsuit against FDA over weight loss drugs

Eli Lilly is seeking to end a lawsuit filed by a pharmacy trade group against the Food and Drug Administration (FDA) by ...

Business Insider22d

The shortage of popular weight loss drug tirzepatide is over, FDA says. Patients could see higher costs as a result.

Tirzepatide is the active ingredient in Eli Lilly's drugs Mounjaro and Zepbound ... industry that connects patients with weight loss drugs, as companies like Henry Meds and Hims offer ...

USA Today22d

Off-brand versions of Lilly weight loss drug must be pulled off market, could mean higher prices

The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound ... including semaglutide and tirzepatide, as an option for weight loss," the FDA said last week.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results